Prediction and Management of Recurrences after Catheter Ablation in Atrial Fibrillation and Heart Failure

Majd A. El-Harasis, Christopher V. DeSimone, Xiaoxi Yao, Peter Noseworthy

Research output: Contribution to journalReview article

Abstract

Catheter ablation is recommended in patients with symptomatic atrial fibrillation (AF) refractory to pharmacologic therapy. AF recurrence is common postablation, particularly in patients with heart failure, because of multiple structural and functional changes that can occur. Determining predictors of AF recurrence has become increasingly important. These include increased left atrial volume, termination of AF during the index ablation, electrocardiogram parameters, and serum biomarkers. Cardiac MRI can also determine the degree of scarring and left atrial sphericity, which is used in risk prediction scores. In patients with recurrence, further treatment options include pharmacologic therapy and atrioventricular nodal ablation with pacing.

Original languageEnglish (US)
JournalCardiology clinics
DOIs
StatePublished - Jan 1 2019

Fingerprint

Catheter Ablation
Atrial Fibrillation
Heart Failure
Recurrence
Cicatrix
Electrocardiography
Therapeutics
Biomarkers
Serum

Keywords

  • Atrial fibrillation
  • Cardiac resynchronization therapy
  • Catheter ablation
  • Heart failure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Prediction and Management of Recurrences after Catheter Ablation in Atrial Fibrillation and Heart Failure. / El-Harasis, Majd A.; DeSimone, Christopher V.; Yao, Xiaoxi; Noseworthy, Peter.

In: Cardiology clinics, 01.01.2019.

Research output: Contribution to journalReview article

@article{dd02edbd35b24974a45237b3888fd261,
title = "Prediction and Management of Recurrences after Catheter Ablation in Atrial Fibrillation and Heart Failure",
abstract = "Catheter ablation is recommended in patients with symptomatic atrial fibrillation (AF) refractory to pharmacologic therapy. AF recurrence is common postablation, particularly in patients with heart failure, because of multiple structural and functional changes that can occur. Determining predictors of AF recurrence has become increasingly important. These include increased left atrial volume, termination of AF during the index ablation, electrocardiogram parameters, and serum biomarkers. Cardiac MRI can also determine the degree of scarring and left atrial sphericity, which is used in risk prediction scores. In patients with recurrence, further treatment options include pharmacologic therapy and atrioventricular nodal ablation with pacing.",
keywords = "Atrial fibrillation, Cardiac resynchronization therapy, Catheter ablation, Heart failure",
author = "El-Harasis, {Majd A.} and DeSimone, {Christopher V.} and Xiaoxi Yao and Peter Noseworthy",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.ccl.2019.01.010",
language = "English (US)",
journal = "Cardiology Clinics",
issn = "0733-8651",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Prediction and Management of Recurrences after Catheter Ablation in Atrial Fibrillation and Heart Failure

AU - El-Harasis, Majd A.

AU - DeSimone, Christopher V.

AU - Yao, Xiaoxi

AU - Noseworthy, Peter

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Catheter ablation is recommended in patients with symptomatic atrial fibrillation (AF) refractory to pharmacologic therapy. AF recurrence is common postablation, particularly in patients with heart failure, because of multiple structural and functional changes that can occur. Determining predictors of AF recurrence has become increasingly important. These include increased left atrial volume, termination of AF during the index ablation, electrocardiogram parameters, and serum biomarkers. Cardiac MRI can also determine the degree of scarring and left atrial sphericity, which is used in risk prediction scores. In patients with recurrence, further treatment options include pharmacologic therapy and atrioventricular nodal ablation with pacing.

AB - Catheter ablation is recommended in patients with symptomatic atrial fibrillation (AF) refractory to pharmacologic therapy. AF recurrence is common postablation, particularly in patients with heart failure, because of multiple structural and functional changes that can occur. Determining predictors of AF recurrence has become increasingly important. These include increased left atrial volume, termination of AF during the index ablation, electrocardiogram parameters, and serum biomarkers. Cardiac MRI can also determine the degree of scarring and left atrial sphericity, which is used in risk prediction scores. In patients with recurrence, further treatment options include pharmacologic therapy and atrioventricular nodal ablation with pacing.

KW - Atrial fibrillation

KW - Cardiac resynchronization therapy

KW - Catheter ablation

KW - Heart failure

UR - http://www.scopus.com/inward/record.url?scp=85061304439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061304439&partnerID=8YFLogxK

U2 - 10.1016/j.ccl.2019.01.010

DO - 10.1016/j.ccl.2019.01.010

M3 - Review article

C2 - 30926023

AN - SCOPUS:85061304439

JO - Cardiology Clinics

JF - Cardiology Clinics

SN - 0733-8651

ER -